Family Intervention for Black Teens With Type 1 Diabetes
NCT06275412
Summary
The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).
Eligibility
Inclusion Criteria: * Age: 10 years, 0 months - 14 years, 11 months * Diagnosed with Type 1 diabetes * Diagnosed for at least 6 months * Black * Primary caregiver willing to participate * Residence within 30 miles of a recruitment site * Caregiver ownership of an Internet-enabled device (cell phone, laptop or desktop computer, tablet, etc) Exclusion Criteria: * Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality) * Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis) * Inability to speak or read English * Child is in out-of-home placement
Conditions3
Locations4 sites
District of Columbia
1 siteMichigan
1 siteTennessee
2 sitesBrowse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06275412